Literature DB >> 6208274

Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils.

E J Goetzl, D G Payan.   

Abstract

The release of mediators from unpurified human basophils challenged with anti-human myeloma IgE serum was suppressed significantly by somatostatin at respective concentrations of 3 x 10(-13) M to 10(-9) M for histamine and 10(-13) M to 10(-11) M for leukotriene D4, which had no effect on release elicited by ionophore A23187. A direct effect of picomole-nanomole concentrations of somatostatin on basophils predominated, as shown by the significant inhibition of immunologically stimulated mediator release from monocyte-free human basophils of 15 to 32% purity and from rat basophil leukemia cells. The dependence of basophil inhibition on the conformation of somatostatin was suggested by the lower potency of reduced and alkylated somatostatin and the lack of inhibitory activity of [D-Trp8] somatostatin. Somatostatin thus may mediate suppressive effects of sensory nerves in some basophil-dependent hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208274

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Effect of substance P and somatostatin on migration of polymorphonuclear (PMN) cells in vitro.

Authors:  G Partsch; M Matucci-Cerinic
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

2.  Measles virus modulates human T-cell somatostatin receptors and their coupling to adenylyl cyclase.

Authors:  S Krantic; A Enjalbert; C Rabourdin-Combe
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease.

Authors:  H Yamamoto; K Morise; K Kusugami; A Furusawa; T Konagaya; Y Nishio; H Kaneko; K Uchida; H Nagai; T Mitsuma; H Nagura
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

4.  Study of the effect of some neuropeptides and endogenous opioid peptides on in vitro histamine release from human lung mast cells and peripheral blood basophils.

Authors:  A Miadonna; E Leggieri; A Tedeschi; M Lorini; M Froldi; C Zanussi
Journal:  Agents Actions       Date:  1988-08

5.  Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells.

Authors:  M A Lowman; R C Benyon; M K Church
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

6.  Expression of the somatostatin gene in human astrocytoma cell lines.

Authors:  L Mercure; G S Tannenbaum; H M Schipper; D Phaneuf; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

7.  Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes.

Authors:  L Mercure; D Phaneuf; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

Review 8.  Neuroendocrine modulation of the immune system. Possible implications for inflammatory bowel disease.

Authors:  F Shanahan; P Anton
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

9.  Somatostatin effectively prevents ethanol- and NSAID-induced gastric mucosal damage in rats.

Authors:  F Karmeli; R Eliakim; E Okon; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

10.  Somatostatin in inflammatory bowel disease.

Authors:  J D van Bergeijk; J H Wilson
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.